1. Home
  2. INDV vs PAY Comparison

INDV vs PAY Comparison

Compare INDV & PAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Indivior PLC

INDV

Indivior PLC

N/A

Current Price

$35.64

Market Cap

4.2B

Sector

Health Care

ML Signal

N/A

Logo Paymentus Holdings Inc.

PAY

Paymentus Holdings Inc.

N/A

Current Price

$32.62

Market Cap

4.6B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
INDV
PAY
Founded
1994
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
4.6B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
INDV
PAY
Price
$35.64
$32.62
Analyst Decision
Strong Buy
Buy
Analyst Count
4
8
Target Price
★ $49.50
$40.14
AVG Volume (30 Days)
★ 2.2M
677.9K
Earning Date
10-29-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 8100.00
48.57
EPS
★ 2.78
0.36
Revenue
★ $1,239,000,000.00
$1,196,507,000.00
Revenue This Year
$7.50
$21.19
Revenue Next Year
$5.07
$17.87
P/E Ratio
★ $12.59
$89.31
Revenue Growth
4.29
★ 37.25
52 Week Low
$27.68
$20.11
52 Week High
$42.81
$45.31

Technical Indicators

Market Signals
Indicator
INDV
PAY
Relative Strength Index (RSI) 53.02 51.14
Support Level $32.90 $29.13
Resistance Level $35.93 $34.16
Average True Range (ATR) 1.41 1.20
MACD 0.12 0.16
Stochastic Oscillator 68.87 66.00

Price Performance

Historical Comparison
INDV
PAY

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

About PAY Paymentus Holdings Inc.

Paymentus Holdings Inc provides electronic bill presentment and payment services, enterprise customer communication and self-service revenue management to billers through a Software-as-a-Service (SaaS), secure, omni-channel technology platform. The platform integrates with a biller's financial and operational systems to provide secure and flexible processing of payments, including credit cards, debit cards, eChecks, and digital wallets, across multiple channels such as online, mobile, IVR, call centers, chatbots, and voice-based assistants. The company generates the majority of its revenue from payment transaction fees processed through its platform. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: